Please use this identifier to cite or link to this item: http://hdl.handle.net/10397/88066
PIRA download icon_1.1View/Download Full Text
Title: Psychometric testing of the functional assessment of cancer therapy/gynecologic oncology group-neurotoxicity (FACT/GOG-Ntx) subscale in a longitudinal study of cancer patients treated with chemotherapy
Authors: Cheng, HL 
Lopez, V
Lam, SC 
Leung, AKT
Li, YC
Wong, KH
Au, JSK
Sundar, R
Chan, A
De Ng, TR
Suen, LKP 
Chan, CW 
Yorke, J 
Molassiotis, A 
Issue Date: 2020
Source: Health and quality of life outcomes, 2020, v. 18, 246, p. 1-9
Abstract: Background The aim of this study was to evaluate the psychometric properties of the Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity (FACT/GOG-Ntx) subscale in a longitudinal study of cancer patients treated with chemotherapy.
Methods Patients were assessed with the FACT/GOG-Ntx subscale, European Organization for Research and Treatment of Cancer Quality of Life Questionnaire Chemotherapy-Induced Peripheral Neuropathy Scale 20 (EORTC QLQ-CIPN20), National Cancer Institute -Common Terminology Criteria for Adverse Events (NCI-CTCAE), and light touch test using 10 g monofilament for up to ten assessment points from baseline (prior to initiation of first chemotherapy), after the end of each cycle (up to 6 cycles, 3 weeks per cycle), and at 6, 9, and 12 months after starting chemotherapy. Psychometric analyses included internal consistency reliability, convergent validity, factorial validity, sensitivity to change and responsiveness (minimal clinically important difference, MCID).
Results Cronbach's alpha coefficients of the FACT/GOG-Ntx subscale were 0.82-0.89 across assessment points. The subscale strongly correlated with the EORTC QLQ-CIPN20 (r = 0.79-0.93) but low-to-moderately correlated with the NCI-CTCAE sensory (r(s) = 0.23-0.45) and motor items (r(s) = 0.15-0.50) as well as the monofilament test (r(s) = 0.23-0.47). The hypothesized 4-factor structure of the FACT/GOG-Ntx subscale was not confirmed at assessment points (chi 2/df = 2.26-8.50; allP < 0.001). The subscale exhibited small-to-moderate sensitivity to change (r = 0.17-0.37). The MCIDs were between 1.38 and 3.68. Conclusion The FACT/GOG-Ntx subscale has satisfactory reliability, validity, sensitivity to change and responsiveness to evaluate CIPN in cancer patients. Future research is needed to explore the factorial structure of the FACT/GOG-Ntx subscale as the published four-factor structure was not supported in this study.
Keywords: Chemotherapy
Peripheral neuropathy
FACT
GOG-Ntx
EORTC QLQ-CIPN20
Psychometrics
Responsiveness
Confirmatory factor analysis
Publisher: BioMed Central
Journal: Health and quality of life outcomes 
EISSN: 1477-7525
DOI: 10.1186/s12955-020-01493-y
Rights: © The Author(s). 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
The following publication Cheng, H. L., Lopez, V., Lam, S. C., Leung, A. K. T., Li, Y. C., Wong, K. H., . . . Molassiotis, A. (2020). Psychometric testing of the functional assessment of cancer therapy/gynecologic oncology group-neurotoxicity (FACT/GOG-Ntx) subscale in a longitudinal study of cancer patients treated with chemotherapy. Health and Quality of Life Outcomes, 18, 1-9 is available at https://dx.doi.org/10.1186/s12955-020-01493-y
Appears in Collections:Journal/Magazine Article

Files in This Item:
File Description SizeFormat 
Cheng_Psychometric_Testing_Cancer.pdf561.51 kBAdobe PDFView/Open
Open Access Information
Status open access
File Version Version of Record
Access
View full-text via PolyU eLinks SFX Query
Show full item record

Page views

93
Last Week
1
Last month
Citations as of May 5, 2024

Downloads

52
Citations as of May 5, 2024

SCOPUSTM   
Citations

24
Citations as of Apr 26, 2024

WEB OF SCIENCETM
Citations

24
Citations as of May 2, 2024

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.